Valiant Lab IPO subscribed 2
时间:2024-06-26 07:22:56 阅读(143)
The Initial Public Offering (IPO) of pharmaceutical ingredient manufacturing firm Valiant Laboratories was subscribed 2.17 times on the third day of bidding on Friday.
The initial share sale received bids for 1,65,77,925 shares against 76,23,030 shares on offer, as per NSE data.
Price range for the offer is Rs 133-140 a share.
The IPO is an entirely fresh issuance of up to 1.08 crore equity shares.
Proceeds of the issue will be utilised to set up a manufacturing facility for speciality chemicals in Gujarat through its subsidiary — Valiant Advanced Sciences Private Ltd — and to meet the working capital requirements of the subsidiary company.
Valiant Laboratories is an active pharmaceutical ingredient or bulk drug manufacturing company with its focus on manufacturing paracetamol, used in the treatment of headaches, muscle aches, arthritis, backache, toothache, cold and fever.
Unistone Capital is the manager to the offer.
Equity shares of the company will be listed on the BSE and the NSE.
猜你喜欢
- Gold Price Today, 30 Nov 2022- Prices higher as dollar falls; investors eye Fed chair Powell’s speech
- Gold Price Today, September 27, 2023- MCX gold slips 0
- NDTV says share transfer needs I-T dept nod, Adani rejects claim
- Gold to experience bargain buying in short-term on weak Indian Rupee; US inflation, retail sales data eyed
- Gold Price Today, 7 Oct- MCX Gold set to hit Rs 52000, silver tops Rs 61600; US nonfarm payrolls data eyed
- Nifty above 18300 to hit new all-time soon; outperformance in Bank Nifty likely to continue in near-term
- Nifty closes near 21,658
- Govt unlikely to permit additional sugar exports this year due to slight fall in production
- Gold sees heightened volatility, supported by US CPI; trend neutral to negative, assume longs at Rs 58,000